CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
50.91
-1.07 (-2.07%)
Feb 5, 2026, 12:53 PM EST - Market open
CG Oncology Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$70.00
Upside
+37.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $61 → $73 | Buy | Maintains | $61 → $73 | +43.40% | Jan 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $55 → $70 | Buy | Maintains | $55 → $70 | +37.51% | Jan 16, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $62 → $66 | Strong Buy | Maintains | $62 → $66 | +29.65% | Jan 12, 2026 |
| Wedbush | Wedbush | Buy Initiates $70 | Buy | Initiates | $70 | +37.51% | Dec 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +21.80% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $53 → $61 | Buy | Maintains | $53 → $61 | +19.83% | Nov 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +76.80% | Oct 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $41 → $47 | Buy | Maintains | $41 → $47 | -7.67% | Sep 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $56 → $79 | Buy | Maintains | $56 → $79 | +55.19% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +47.33% | Sep 15, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | -1.78% | Sep 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $75 | Buy | Reiterates | $75 | +47.33% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +47.33% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +47.33% | Sep 5, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $55 | Buy | Initiates | $55 | +8.04% | Aug 19, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $68 → $53 | Buy | Maintains | $68 → $53 | +4.12% | Jul 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.